SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings (ONDS) is currently trending due to its subsidiary, Airobotics, being selected as the prime contractor for Israel's crucial 'Drone Hives' border security initiative, highlighting its growing presence in defense technology. This development, coupled with broader geopolitical tensions and increasing global defense spending on autonomous and counter-UAS systems, has ignited significant bullish sentiment among investors ahead of an anticipated Investor Day.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion is trending following a corporate outlook highlighting triple-digit growth for its AI back pain platform, Nociscan, alongside a strong financial position and ongoing clinical trials. Community discussion is vibrant, with many anticipating a significant short squeeze due to the company's very low share float and promising technology. However, a notable portion of the community expresses caution, citing past share dilutions and concerns about market manipulation.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending due to market concerns over its innovation in the AI space and its recent stock underperformance, with Alphabet reportedly surpassing its market capitalization. While many express frustration with the stock's downtrend amid broader market highs, a segment of the community sees current levels as a buying opportunity ahead of anticipated strong earnings and future product developments.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following positive FDA Type B meeting feedback, which indicates a clear regulatory path for its HS drug without requiring additional clinical trials. The community is highly bullish, with many anticipating significant upside and potential acquisition interest, interpreting recent management actions and regulatory silence as strong signals for a strategic transaction.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending after reporting robust earnings that significantly surpassed revenue and EPS expectations, driven by strong growth in its AI and high-performance computing hosting business. The community is actively discussing the successful operationalization of its data centers and advanced negotiations for substantial new hyperscaler contracts, which could notably expand its contracted revenue. These developments, along with a strategic spin-off, are fueling bullish sentiment for long-term growth and sparking conversations around a potential short squeeze.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF (DIA) is drawing significant attention after recently achieving new record highs, coinciding with impactful geopolitical developments that sparked initial market reactions. Community members are actively debating whether these strong gains reflect genuine economic momentum or if institutional activity is influencing index performance and masking underlying market fragilities.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is experiencing heightened interest following renewed discussions around increased defense spending and recent positive analyst coverage highlighting its robust financial profile within the AI and defense sectors. The community is actively debating its valuation while anticipating significant government and commercial contract opportunities, fueling a strong bullish sentiment around its disruptive AI capabilities.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as market participants keenly await an upcoming Supreme Court ruling on tariffs, alongside broad discussions about fresh jobs data and escalating geopolitical tensions. This combination fuels a stark divergence in community sentiment; many anticipate a significant market pullback from current highs, while a resilient segment expects continued strength, buoyed by the enduring enthusiasm for AI-driven growth. The ETF's elevated positioning has investors actively debating its susceptibility to external shocks versus its capacity for further upside.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is a key focus for investors as they await a significant Supreme Court ruling on tariffs, sparking intense community debate on its potential market and inflation implications. This creates a polarized sentiment, with some highlighting perceived manipulation and signs of reversal, while others remain optimistic, actively discussing buying opportunities within the tech-heavy index driven by strong AI and semiconductor demand.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is trending due to an exceptionally high cost to borrow and an extreme scarcity of shares available for shorting, driving intense community speculation about a significant short squeeze. Traders are actively drawing parallels to prior explosive moves seen in other low-float stocks, despite ongoing discussions about the company's underlying fundamentals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall St is expecting 0.06 EPS for $BJRI Q3 [Reporting 10/23 AMC]
http://www.estimize.com/intro/bjri?chart=historical&amp;metric_name=eps&amp;utm_co